MARIETTA, Ga. — Owen Mumford is introducing Unifine Ultra, what they are calling the world’s most extraordinary home use pen needle.

People with diabetes are continually looking for ways to improve the injection therapy experience while doctors and pharmacists want to improve patient adherence and compliance. Unifine Ultra is a one of a kind home use pen needle that is designed to offer the ultimate solution to help improve patient compliance and enhance the injection experience.

Unifine Ultra is ergonomically constructed for ease of use. The unique design includes a flat base to help improve skin contact and enhance comfort in addition too, the large hub design which aides with grip and handling. The Unifine Ultra pen needle incorporates Owen Mumford’s patented SafeControl Technology, a needle lock-out feature that secures both ends of the needle. This patented lock-out feature not only assists in encouraging patient compliance but also makes Unifine Ultra the optimal choice for convenience at home or on-the-go.

“I am incredibly proud of the work completed by our Product Management, Marketing and Research & Development Teams,” said Travis Shaw, executive vice president Owen Mumford. “Their dedication and tireless efforts in assisting to bring Unifine Ultra to market is a testament to Owen Mumford’s mission, Making a World of Difference to a World of People. The Unifine Ultra introduction compliments Owen Mumford’s already expansive pen needle portfolio, by adding unique features and innovative technologies, with the consumer in mind.”

Unifine Ultra is the only pen needle of its kind and brings the same quality and value that is expected from the Unifine brand. Unifine Ultra is available in a comprehensive range of sizes including 4mmx32G, 5mmx31G, 6mmx31G and 8mmx31G.